Organon Pharmaceutical’s NuvaRing, a “third generation” of birth control, advertises that it contains a lower dose of hormones than other oral contraceptives. However, while oral contraceptives – such as birth control pills – lose up to half of their hormones in the body’s digestive tract, NuvaRing hormones are absorbed directly into the bloodstream. So, is that a good thing? The answer is that nobody seems to know.
Fear Of The Unknown
NuvaRing’s own labeling says that it is “unknown” how the vaginal ring device compares to other forms of hormonal birth control. NuvaRing uses a chemical compound related to desogestrel – a third-generation hormone that was supposed to decrease the pill’s side effects of acne and facial hair. However, it has never been shown that these side effects have decreased.
What research has shown is that NuvaRing, and other forms of third-generation birth control, can double the risk of blood clots and lead to serious side effects such as:
- Blood clots
- Death caused by blood clot (pulmonary embolism, stroke or heart attack)
- Deep vein thrombosis (DVT)
- Heart attack
- Liver cancer
- Pulmonary embolism (blood clots in the lung(s))
Unfortunately, this fear of the unknown has become all too well known for many women who have suffered NuvaRing injuries – as evidenced by the 1,200 NuvaRing injury lawsuits now pending in U.S. state and federal courts.
NuvaRing Injury Attorneys Can Help
NuvaRing injury attorneys say that Organon Pharmaceuticals, the company which developed NuvaRing, and Schering-Plough Corporation, which acquired Organon and then merged with Merck & Co., never fully studied how NuvaRing hormones and delivery affect women before the companies marketed the device. If you’ve been injured by a NuvaRing, The Driscoll Firm, LLC, can help you to determine whether you might be entitled to compensation for your injuries, such as medical bills, lost income, pain and suffering and more.